ondansetron has been researched along with Cirrhosis, Liver in 3 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary biliary cirrhosis (PBC), autoimmune cholangitis (AIC = AMA-negative PBC) and primary sclerosing cholangitis (PSC) are autoimmune cholestatic liver diseases." | 2.42 | [Cholestatic liver diseases]. ( Blum, HE; Kreisel, W; Opitz, OG; Thimme, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thimme, R | 1 |
| Opitz, OG | 1 |
| Blum, HE | 1 |
| Kreisel, W | 1 |
| Li, T | 1 |
| Weng, SG | 1 |
| Leng, XS | 1 |
| Peng, JR | 1 |
| Wei, YH | 1 |
| Mou, DC | 1 |
| Wang, WX | 1 |
| Tripkovic, M | 1 |
| Kozjek, F | 1 |
| Krizman, I | 1 |
| Jereb, J | 1 |
| Francetic, I | 1 |
| Grabnar, I | 1 |
| Mrhar, A | 1 |
1 review available for ondansetron and Cirrhosis, Liver
| Article | Year |
|---|---|
[Cholestatic liver diseases].
Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruriti | 2004 |
1 trial available for ondansetron and Cirrhosis, Liver
| Article | Year |
|---|---|
Effects of ondansetron on portal hemodynamics in liver cirrhosis.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Double-Blind Method; Female; Hemodynamics; Humans; Hyperte | 2000 |
1 other study available for ondansetron and Cirrhosis, Liver
| Article | Year |
|---|---|
Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells.
Topics: Animals; Blotting, Western; Cells, Cultured; Gene Expression; Ketanserin; Liver; Liver Cirrhosis; Ma | 2006 |